Skip to content

Intervention for Sustained Testing and Retention Among HIV-infected Patients

Intervention for Sustained Testing and Retention Among HIV-infected Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03018002
Acronym
iSTAR
Enrollment
400
Registered
2017-01-11
Start date
2016-07-31
Completion date
2020-03-31
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, PMTCT

Brief summary

The purpose of this study is to evaluate the comparative effectiveness of a congregation, clinic and integrated case management-based intervention for sustainable testing and retention on linkage to care, engagement, retention and viral load suppression of women and children infected with HIV.

Detailed description

Using a two-arm cluster randomized design, our proposed study will evaluate the comparative effectiveness of iSTAR, a community-based social network intervention that combines trained church-based Health Advisors and clinic-based staff and uses motivational interview skills and clinic- quality improvement approaches (Intervention Group; IG) versus a clinic-based approach (Control group; CG) on linkage, engagement, retention and viral suppression among HIV-infected women and children. Eighteen health facilities in identified local government areas in Benue state, north-central Nigeria will be randomly assigned to either the IG (N=9 health facilities) or the CG (N=9 health facilities). A total of 10,000 pregnant women will be screened and 400 HIV-infected participants will be enrolled over a 24-month period. The primary outcome will be the difference in the rate of linkage and engagement between the groups. The secondary outcome will be the difference in rate of retention and viral suppression among participants. Additionally, we will conduct network, mediation/moderation analysis to examine the roles of intermediate variables such as health team cohesion, turnovers, attitudes, leadership and dynamic adaptation on iSTAR implementation and sustainment.

Interventions

OTHERiSTAR

Each component of the iSTAR intervention targets a specific point along the HIV continuum: confidential, onsite integrated laboratory tests during baby showers targets HIV diagnosis (b) church-based Health Advisors (CHAs) trained in motivational interviewing and quality improvement skills as promotoras target linkage, engagement and adherence by providing counseling and other support to HIV-infected women and children (c) integrated network of community and clinic case management targets reduction in loss to follow-up. CHAs will support participants during the study period by being available to accompany them to clinic visits, review laboratory results and medications after clinic visits. They will be available to speak with them at intervals to see how they are doing either by phone or through home visits as they prefer. At each follow-up study visit, the trained CHA will review and collect data on participants' clinic visits, treatment, and laboratory results.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Nevada, Las Vegas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV-infected pregnant women identified during baby showers programs at participating worship centers.

Exclusion criteria

* HIV-infected women already on treatment

Design outcomes

Primary

MeasureTime frameDescription
Linkage in care1 monthLinkage in care is defined as the percentage of participants with at least one HIV medical care visit following HIV diagnosis.
Retention in care12 monthsRetention is defined as the percentages of participants with two or more documented viral load measurement during the 12 months following enrollment.

Secondary

MeasureTime frameDescription
ART Initiation1 monthThe secondary outcome is engagement in care defined as the percentage of participants initiated on ART at 1 month following enrollment.
Viral Suppression12 monthsViral suppression is defined as the percentage of participants whose most recent two viral load are \<20 copies/mL.

Countries

Nigeria

Contacts

Primary ContactEchezona Ezeanolue, MD, MPH
echezona.ezeanolue@unlv.edu7028952687
Backup ContactChima Onoka, MD, PhD
chima.onoka@unn.edu.ng+2348033802711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026